Optical Tracking and Digital Quantification of Beating Behavior in Bioengineered Human Cardiac Organoids
Open Access
- 23 June 2017
- journal article
- research article
- Published by MDPI AG in Biosensors
- Vol. 7 (3), 24
- https://doi.org/10.3390/bios7030024
Abstract
Organoid and organ-on-a-chip technologies are rapidly advancing towards deployment for drug and toxicology screening applications. Liver and cardiac toxicities account for the majority of drug candidate failures in human trials. Liver toxicity generally produces liver cell death, while cardiac toxicity causes adverse changes in heart beat kinetics. In traditional 2D cultures, beating kinetics can be measured by electrode arrays, but in some 3D constructs, quantifying beating kinetics can be more challenging. For example, real time measurements of calcium flux or contractile forces are possible, yet rather complex. In this communication article, we demonstrate a simple sensing system based on software code that optically analyzes video capture files of beating cardiac organoids, translates these files in representations of moving pixels, and quantifies pixel movement activity over time to generate beat kinetic plots. We demonstrate this system using bioengineered cardiac organoids under baseline and drug conditions. This technology offers a non-invasive, low-cost, and incredibly simple method for tracking and quantifying beating behavior in cardiac organoids and organ-on-a-chip systems for drug and toxicology screening.Keywords
Funding Information
- Defense Threat Reduction Agency (Space and Naval Warfare Systems Center Pacific (SSC PACIFIC) Contract No. N6601-13-C-2027)
This publication has 19 references indexed in Scilit:
- Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modelingDrug Discovery Today, 2016
- A reductionist metastasis‐on‐a‐chip platform for in vitro tumor progression modeling and drug screeningBiotechnology & Bioengineering, 2016
- In situ patterned micro 3D liver constructs for parallel toxicology testing in a fluidic deviceBiofabrication, 2015
- Engineered In Vitro Disease ModelsAnnual review of pathology, 2015
- Organ-on-a-chip platforms for studying drug delivery systemsJournal of Controlled Release, 2014
- HeLiVa platform: integrated heart-liver-vascular systems for drug testing in human health and diseaseStem Cell Research & Therapy, 2013
- Biomimetic tissues on a chip for drug discoveryDrug Discovery Today, 2012
- From 3D cell culture to organs-on-chipsTrends in Cell Biology, 2011
- Current challenges in the evaluation of cardiac safety during drug development: Translational medicine meets the Critical Path InitiativeAmerican Heart Journal, 2009
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003